Results 131 to 140 of about 153,772 (207)

Coagulation profiles during and after anabolic androgenic steroid use: data from the HAARLEM study. [PDF]

Res Pract Thromb Haemost, 2023
Camilleri E, Smit DL, van Rein N, Le Cessie S, de Hon O, den Heijer M, Lisman T, Cannegieter SC, de Ronde W.   +8 more
europepmc   +1 more source

Relationship Between Anabolic-Androgenic Steroid Use, Aggression, and Narcissism in Male Bodybuilders. [PDF]

Medicina (Kaunas)
Ceto E, Yigitoglu PH, Yavuz HU.
europepmc   +1 more source

Development of Liver Cancers as an Unexpected Consequence of Anabolic Androgenic Steroid Use. [PDF]

Cureus, 2023
Khalid S, Laput G, Khorfan K, Roytman M.
europepmc   +1 more source

Anabolic-androgenic steroid use disorder: case for recognition as a substance use disorder with specific diagnostic criteria. [PDF]

Br J Psychiatry
Scarth M, Havnes IA, Bjørnebekk A.
europepmc   +1 more source

The use of post-cycle therapy is associated with reduced withdrawal symptoms from anabolic-androgenic steroid use: a survey of 470 men. [PDF]

Subst Abuse Treat Prev Policy, 2023
Grant B, Kean J, Vali N, Campbell J, Maden L, Bijral P, Dhillo WS, McVeigh J, Quinton R, Jayasena CN.   +9 more
europepmc   +1 more source

Harm reduction measures in a recreational gym user with anabolic androgenic steroid dependence: a case report in the context of current best clinical practice. [PDF]

Harm Reduct J
Magnolini R, Bottoni SL, Hammer H, Capraro J, Bruggmann P, Senn O.   +5 more
europepmc   +1 more source

Rapid Resolution of Anabolic Androgenic Steroid-Induced Refractory Pruritus and Bile Cast Nephropathy With Therapeutic Plasma Exchange. [PDF]

JGH Open
Wong S, Con D, Majumdar A.
europepmc   +1 more source

"Injecting yourself there is stigma around it; taking a few tablets is not too bad, is it?": understanding perceptions and preferences of anabolic-androgenic steroid route of administration. [PDF]

Harm Reduct J
Cox L, Piatkowski T, Dunn M.
europepmc   +1 more source

Anabolic-androgenic steroid testing as a tool for consumer engagement and harm reduction: a sequential explanatory mixed-method study. [PDF]

Harm Reduct J
Piatkowski T, Coomber R, Francis C, Kill E, Davey G, Cresswell S, White A, Harding M, Blakey K, Reeve S, Walters B, Puljević C, Ferris J, Barratt MJ.   +13 more
europepmc   +1 more source

Non-ischemia Cardiomyopathy and Polycythemia Secondary to Anabolic-Androgenic Steroid Use. [PDF]

Cureus
Rudy R, Basree M, Jacob A, Raj R.
europepmc   +1 more source